COGT

News Cogent Bio granted FDA priority review for lead asset in tumor indication

5d ago

Short volume Short volume 86% of volume (10.3σ)

5d ago

Short volume Short volume 52% of volume (4.9σ)

9d ago

News Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

14d ago

News Cogent (COGT) Up on SUMMIT Study Update Post Positive FDA Meeting

14d ago

News This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch

14d ago

News Stanley Druckenmiller's Duquesne initiates stake in AVGO, dumps GOOGL among Q1 moves

17d ago

News Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application

77d ago

Insider trade Sale by Fairmount Funds Management LLC

104d ago

SEC filing COGT Reports Fourth Quarter and Full Year 2025 Financials, Submits SUMMIT NDA, Initiates PEAK NDA, Tracks APEX NDA Submission, Strong Balance Sheet with $901M Cash Position

105d ago

News Ameris Bancorp outlines mid-single-digit loan and deposit growth targets for 2026 amid record profitability

122d ago

News Ameris Bancorp (ABCB) Q4 2025 Earnings Transcript

122d ago

News Cogent Biosciences stock falls after multiple insider sales

153d ago

News Cogent Biosciences down after market close on insider sales

153d ago

Insider trade Sale by Kearns Evan (Chief Legal Officer)

153d ago

Insider trade Sale by Green John L. (Chief Financial Officer)

153d ago

Insider trade Sale by Sachs Jessica (Chief Medical Officer)

153d ago

Insider trade Sale by Robinson John Edward (Chief Scientific Officer)

153d ago